Associate Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School
Endocrinology
Dr. Allison Goldfine, MD
|
|
Give Review
Doctor Allison Goldfine, MD works in the field of Endocrinology. She graduated from Perelman School of Medicine at the University of Pennsylvania. She received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Diabetes Recognition Program". Allison Goldfine, MD is also a published doctor. She has 98 publication published. The most recent publication is: Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. She accepts Medicare payments and is listed with Medicare.gov.
Publications
- Effect of paricalcitol on endothelial function and inflammation in type 2 Diabetes and chronic kidney disease.
- Insulin response to oral stimuli and glucose effectiveness increased in neuroglycopenia following gastric bypass.
- Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 Diabetes mellitus.
- Atazanavir improves cardiometabolic measures but not vascular function in patients with long-standing type 1 Diabetes mellitus.
- Visceral Adiposity and the Risk of Metabolic Syndrome Across Body Mass Index: The MESA Study.
- Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 Diabetes: a cohort study.
- Glycemia and cognitive function in metabolic syndrome and coronary heart disease.
- Weight loss and progressive left ventricular remodelling: The Multi-Ethnic Study of Atherosclerosis (MESA).
- Insulin regulates carboxypeptidase E by modulating translation initiation scaffolding protein eIF4G1 in pancreatic β cells.
- Roux-en-Y Gastric Bypass Surgery or Lifestyle With Intensive Medical Management in Patients With Type 2 Diabetes: Feasibility and 1-Year Results of a Randomized Clinic...
- Dipeptidyl peptidase-4 inhibitors in type 2 Diabetes may reduce the risk of autoimmune diseases: a population-based cohort study.
- Diabetes Improvement Following Roux-en-Y Gastric Bypass: Understanding Dynamic Changes in Insulin Secretion and Action.
- Impaired Fasting Glucose and Body Mass Index as Determinants of Mortality in ALLHAT: Is the Obesity Paradox Real?
- Hypoglycemia After Gastric Bypass: The Dark Side of GLP-1.
- Fasting Serum Taurine-conjugated Bile Acids are Elevated in Type 2 Diabetes: and Do Not Change with Intensification of Insulin.
- Where Are the Health Care Cost Savings With Bariatric Surgery in Obesity Management?
- The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes.
- Diabetes: Bariatric surgery for T2DM-cure, or remission and relapse?
- Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes (TINSAL): Effects on flow-mediated dilation.
- Salicylate (salsalate) in patients with type 2 Diabetes: a randomized trial.
- A specific and sensitive assay for blood levels of glycated CD59: A novel biomarker for Diabetes.
- Metabolic surgery for type 2 Diabetes: efficacy and risks.
- A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons With abnormal glucose tolerance.
- The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH): Design of a pharmacogenetic Resource for Type 2 Diabetes.
- Molecular basis for a link between complement and the vascular complications of Diabetes.
- Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study.
- Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes.
- Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients With severe hyperinsulinaemic hypoglycaemia following gastric bypass.
- Hypoglycaemia following gastric bypass surgery--Diabetes remission in the extreme?
- Family history of Diabetes impacts on interactions between minimal model estimates of insulin sensitivity and glucose effectiveness.
- Patients With neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.
- Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia.
- The role of total and high-molecular-weight complex of adiponectin in vascular function in offspring whose parents both had type 2 Diabetes.
- Portal and peripheral cortisol levels in obese humans.
- Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent Diabetes mellitus: in vivo and in vitro studies.
- Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo.
- In vivo and in vitro studies of vanadate in human and rodent Diabetes mellitus.
- Molecular determinants of insulin action.
- Analysis of the insulin receptor gene in noninsulin-dependent Diabetes mellitus by denaturing gradient gel blots: a clinical research center study.
- Insulin allergy and insulin resistance.
- Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent Diabetes mellitus in vivo and in vitro studies.
- Effect of glycemic control on the overnight dexamethasone suppression test in patients with Diabetes mellitus.
- Type 2 Diabetes: new drugs, new perspectives.
- Effect of vanadium(IV) compounds in the treatment of Diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).
- Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans.
- Antegrade intravenous catheterization for metabolic studies in man.
- Prevention of type 2 Diabetes: are we ready?
- Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery.
- Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human Diabetes.
- Ablation of ARNT/HIF1beta in liver alters gluconeogenesis, lipogenic gene expression, and serum ketones.
- The American Journal of Cardiology and Journal of Periodontology Editors'' Consensus: periodontitis and atherosclerotic cardiovascular disease.
- Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in Diabetic patients: a novel target of thiazolidinediones.
- Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters.
- Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans.
- Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acids.
- Fibrates in the treatment of dysLipidemias--time for a reassessment.
- Expression of the Splicing Factor Gene SFRS10 Is Reduced in Human Obesity and Contributes to Enhanced Lipogenesis.
- Obesity and type 2 Diabetes: what can be unified and what needs to be individualized?
- PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans.
- Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance.
- The great debate: medicine or surgery: what is best for the patient with type 2 Diabetes?
- Continuous glucose monitoring for evaluation of glycemic excursions after gastric bypass.
- Cardiovascular safety and Diabetes drug development.
- Biomarkers in fasting serum to estimate glucose tolerance, insulin sensitivity, and insulin secretion.
- Diabetes: advances and controversies.
- Therapeutic approaches to target inflammation in type 2 Diabetes.
- Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging.
- Association between fine particulate matter and Diabetes prevalence in the U.S.
- Confronting the type 2 Diabetes epidemic: the emerging role of incretin-based therapies.
- Protective unfolded protein response in human pancreatic beta cells transplanted into mice.
- Management of Diabetes mellitus in patients with cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
- Inhibition of protein kinase Cbeta does not improve endothelial function in type 2 Diabetes.
- Effect of ranolazine on A1C and glucose levels in hyperglycemic patients With non-ST elevation acute coronary syndrome.
- The effects of salsalate on glycemic control in patients with type 2 Diabetes: a randomized trial.
- Insulin enhances glucose-stimulated insulin secretion in healthy humans.
- Glucagon treatment for post-gastric bypass Hypoglycemia.
- The impact of vitamin D deficiency on Diabetes and cardiovascular risk.
- Rapid identification of myocardial infarction risk associated with Diabetes medications using electronic medical records.
- Thyroid hormone-related regulation of gene expression in human fatty liver.
- Expansion and contraction: treating Diabetes with bariatric surgery.
- The use of colesevelam HCl in patients with type 2 Diabetes mellitus: combining glucose- and lipid-lowering effects.
- Life and death in Denmark: lessons about Diabetes and coronary heart disease.
- The rough road for rosiglitazone.
- Human insulin analog--induced lipoatrophy.
- Salsalate improves glycemia and inflammatory parameters in obese young adults.
- Changing horizons: approaches to Diabetes care, current and future.
- Serum bile acids are higher in humans With prior gastric bypass: potential contribution to improved glucose and lipid metabolism.
- Identification and importance of brown adipose tissue in adult humans.
- Getting away from glucose: fanning the flames of obesity-induced inflammation.
- Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 Diabetes.
- Bariatric surgery for Diabetes management.
- Assessing the cardiovascular safety of Diabetes therapies.
- Modulating LDL cholesterol and glucose in patients with type 2 Diabetes mellitus: targeting the bile acid pathway.
- Lactation after normal pregnancy is not associated With blood glucose fluctuations.
- Endothelial function varies according to insulin resistance disease Type.
- Inflammation and insulin resistance.
- Family history of Diabetes is a major determinant of endothelial function.
Schools
Perelman School of Medicine University of Pennsylvania
University Mass
Joslin Clin
Conditions Treated
- Diabetes Type 1
- Diabetes Type 2
- Diabetes With Renal Manifestations
- Diabetic Macular Edema (DME)
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Diabetes Recognition Program
Education
-
Beth Israel Deaconess Medical Center -
University of Massachusetts -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Beth Israel Deaconess Medical Center
Drug Facts
| NPI NUMBER | 1952470387 | |
| NPPES Provider LastName | GOLDFINE | |
| NPPES Provider FirstName | ALLISON | |
| NPPES Provider ZIPCode | 022155306 | |
| NPPES Provider State | MA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 144.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952470387 |
| Last Name Of The Provider | GOLDFINE |
| First Name Of The Provider | ALLISON |
| View All |
Similar Doctors
|
|
Dr. Nikheel S. Kolatkar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeff Flier, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Clemens Bergwitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naomi D. Fisher, MD
This Doctor is OpenDoctor Recommended.
|